This interim process statement has been produced by the National Institute for Health and Clinical Excellence (NICE) to guide the development of the QIPP key therapeutics document, 'Key therapeutic topics – Medicines management options for local implementation'. It provides an overview of the key process and principles, and describes all stages of the development of the QIPP key therapeutics document. These procedures are designed to ensure that a robust, quality-assured document is developed for the NHS in an open, transparent and timely way, with appropriate input from key groups. This interim process statement uses the NICE Implementation Support Tool process as an overarching guide to the principles of its development.
http://ift.tt/2q7Jelb
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Τετάρτη 10 Μαΐου 2017
Key Therapeutic Topics – Medicines Management Options for Local Implementation: Interim Process Statement [Internet].
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου